@btis.bsky.social
Science, muscle regeneration (muscular dystrophy), music, chess, ...
In a recent @CheckRare feature, Satellos CMO Dr. Wildon Farwell discusses the science behind SAT-3247 and how restoring the #muscleregeneration process could offer a new therapeutic approach for people living with #Duchenne #FSHD $msclf $mscl Watch the interview checkrare.com/new-treatmen...
New Treatment Option (SAT-3247) for Duchenne Muscular Dystrophy Shows Promise in Early Phase Trial
Wildon Farwell, MD, CMO at Satellos, discusses the safety and efficacy of SAT-3247, a new treatment option for Duchenne muscular dystrophy.
checkrare.com
January 23, 2026 at 1:37 AM
In a recent @CheckRare feature, Satellos CMO Dr. Wildon Farwell discusses the science behind SAT-3247 and how restoring the #muscleregeneration process could offer a new therapeutic approach for people living with #Duchenne #FSHD $msclf $mscl Watch the interview checkrare.com/new-treatmen...
Satellos Announces First Participant with Duchenne Muscular Dystrophy (DMD)Dosed in the Phase 1b Clinical Trial of SAT-3247
Up to 10 adult participants with genetically confirmed DMD to be enrolled in the now ongoing Phase 1b trial in DMD patients www.businesswire.com/news/home/20... #DMD #Muscle
Up to 10 adult participants with genetically confirmed DMD to be enrolled in the now ongoing Phase 1b trial in DMD patients www.businesswire.com/news/home/20... #DMD #Muscle
Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a
www.businesswire.com
December 11, 2024 at 12:33 PM
Satellos Announces First Participant with Duchenne Muscular Dystrophy (DMD)Dosed in the Phase 1b Clinical Trial of SAT-3247
Up to 10 adult participants with genetically confirmed DMD to be enrolled in the now ongoing Phase 1b trial in DMD patients www.businesswire.com/news/home/20... #DMD #Muscle
Up to 10 adult participants with genetically confirmed DMD to be enrolled in the now ongoing Phase 1b trial in DMD patients www.businesswire.com/news/home/20... #DMD #Muscle
Reposted
Hot off the press!🔬
Many years of research in our lab have paved the way for a possible treatment of Duchenne Muscular Dystrophy.
ottawacitizen.com/news/local-n...
Many years of research in our lab have paved the way for a possible treatment of Duchenne Muscular Dystrophy.
ottawacitizen.com/news/local-n...
An Ottawa scientist's discovery offers rare hope for patients with devastating genetic disease
An Ottawa stem cell researcher's groundbreaking discovery offers rare hope for patients with the genetic disease.
ottawacitizen.com
November 27, 2024 at 10:04 PM
Hot off the press!🔬
Many years of research in our lab have paved the way for a possible treatment of Duchenne Muscular Dystrophy.
ottawacitizen.com/news/local-n...
Many years of research in our lab have paved the way for a possible treatment of Duchenne Muscular Dystrophy.
ottawacitizen.com/news/local-n...